Innovita Biological Technology Co., Ltd. (688253.SS)
- Previous Close
33.81 - Open
33.61 - Bid 33.38 x --
- Ask 33.40 x --
- Day's Range
33.34 - 34.27 - 52 Week Range
27.56 - 52.69 - Volume
1,997,177 - Avg. Volume
3,214,243 - Market Cap (intraday)
4.558B - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
23.19 - EPS (TTM)
1.44 - Earnings Date --
- Forward Dividend & Yield 0.40 (1.18%)
- Ex-Dividend Date Jun 6, 2024
- 1y Target Est
--
Innovita Biological Technology Co., Ltd. engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; emergency outpatient testing; coronavirus testing; respiratory infections solutions; pregnancy test; hepatitis virus testing ; and enterovirus testing . The company was founded in 2006 and is based in Beijing, China.
www.innovita.com.cnRecent News: 688253.SS
View MorePerformance Overview: 688253.SS
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688253.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688253.SS
View MoreValuation Measures
Market Cap
4.61B
Enterprise Value
2.64B
Trailing P/E
23.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.43
Price/Book (mrq)
2.24
Enterprise Value/Revenue
4.83
Enterprise Value/EBITDA
12.28
Financial Highlights
Profitability and Income Statement
Profit Margin
35.86%
Return on Assets (ttm)
5.08%
Return on Equity (ttm)
9.68%
Revenue (ttm)
546.74M
Net Income Avi to Common (ttm)
196.06M
Diluted EPS (ttm)
1.44
Balance Sheet and Cash Flow
Total Cash (mrq)
1.98B
Total Debt/Equity (mrq)
0.25%
Levered Free Cash Flow (ttm)
205.93M